Nutech Cancer Biomarkers India Private Limited is located in Mumbai, India which is first of its kind, offering SeroMark-1 test service based on blood/serum-based biomarker analysis complementing PSA for prostate cancer screening. SeroMark-1 is awarded patent vide U.S. APPLICATION SERIAL NO. 86072845 and it's an unique and minimally invasive test for early prostate cancer detection that can predict for the presence or absence of prostate cancer in normal appearing men between age 45-65.